Related Experiment Video
Updated: Aug 27, 2025
07:46
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
4.8K
Microfluidic devices: The application in TME modeling and the potential in immunotherapy optimization.
Yuting Li1, Honghong Fan1, Junli Ding1
1Department of Oncology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, China.
Frontiers in Genetics
|September 26, 2022
Summary
Microfluidic systems are advancing cancer research by modeling the tumor microenvironment (TME) to improve immunotherapy. These technologies aid in developing predictive biomarkers and combination therapies for better treatment outcomes.
Area of Science:
- Oncology
- Biotechnology
- Immunotherapy
Background:
- The tumor microenvironment (TME) significantly impacts cancer progression and immunotherapy effectiveness.
- Recent research focuses on biomarkers and combination strategies to enhance immunotherapy responses.
Purpose of the Study:
- To review the application of microfluidic systems in modeling the TME.
- To explore the potential of microfluidics in predicting and monitoring immunotherapy effects.
Main Methods:
- Literature review of microfluidic systems for TME modeling.
- Analysis of microfluidic applications in immunotherapy optimization.
Main Results:
- Microfluidic technology facilitates multi-omics analyses.
- Microfluidic systems can recapitulate the TME in vitro.
- These devices show promise for immunotherapy optimization.
Conclusions:
- Microfluidic systems offer a powerful platform for TME modeling.
- Microfluidics holds potential for predicting and monitoring immunotherapy efficacy.
- This technology can accelerate the development of improved cancer immunotherapies.
